MASSARI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 209
AS - Asia 173
EU - Europa 114
SA - Sud America 16
AF - Africa 1
Totale 513
Nazione #
US - Stati Uniti d'America 198
CN - Cina 98
IE - Irlanda 47
SG - Singapore 38
RU - Federazione Russa 21
HK - Hong Kong 18
BR - Brasile 14
DE - Germania 14
FI - Finlandia 10
VN - Vietnam 9
CA - Canada 8
IT - Italia 8
GB - Regno Unito 4
IN - India 3
BD - Bangladesh 2
ES - Italia 2
MX - Messico 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
EG - Egitto 1
FR - Francia 1
JO - Giordania 1
NL - Olanda 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 513
Città #
Dublin 47
Chandler 41
Beijing 27
Nanjing 19
Hong Kong 18
Dallas 16
Singapore 15
Ashburn 14
Jacksonville 10
Wilmington 8
Boardman 7
Lawrence 7
Princeton 7
Jiaxing 6
Medford 6
Shenyang 6
Hangzhou 5
Ho Chi Minh City 5
Moscow 5
Munich 5
New York 5
Changsha 4
Hebei 4
Helsinki 4
Los Angeles 4
Nanchang 4
Shanghai 4
Buffalo 3
Redondo Beach 3
Berlin 2
Brooklyn 2
Dearborn 2
Hanoi 2
Mexico City 2
Montreal 2
Ottawa 2
São Paulo 2
Toronto 2
Turku 2
Albany 1
Alfenas 1
Amman 1
Ann Arbor 1
Anyang 1
Balsas 1
Bandar Seri Begawan 1
Belford Roxo 1
Belo Horizonte 1
Biên Hòa 1
Brasília 1
Bucharest 1
Cairo 1
Cambé 1
Carapicuíba 1
Charlotte 1
Chicago 1
Currais Novos 1
Dali 1
Dayton 1
Delhi 1
Denver 1
Dhaka 1
Dubai 1
Guangzhou 1
Islamabad 1
Ituzaingó 1
Kyiv 1
London 1
Makati City 1
Missaglia 1
New Delhi 1
New Orleans 1
Ningbo 1
Norwalk 1
Paracatu 1
Parauapebas 1
Phan Thiết 1
Port of Spain 1
Pune 1
Redwood City 1
Ribeirão Preto 1
San Francisco 1
Santa Clara 1
Santa Cruz 1
Seattle 1
Stockholm 1
Tianjin 1
Valença 1
Woodbridge 1
Zurich 1
Totale 380
Nome #
Serum hepcidin in inflammatory bowel diseases: Biological and clinical significance 98
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-α treatment 90
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 75
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: An Italian multicentre study 75
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 71
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 69
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 64
Totale 542
Categoria #
all - tutte 2.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 1 0 5 0 2 0 1
2021/202227 0 0 0 0 0 0 1 1 0 1 6 18
2022/2023116 18 13 3 5 5 11 0 4 51 3 3 0
2023/202432 1 6 0 1 3 9 0 4 1 0 5 2
2024/2025116 4 9 4 3 0 4 3 12 31 6 14 26
2025/2026117 21 15 25 19 34 3 0 0 0 0 0 0
Totale 542